Immediate Impact
77 standout
Citing Papers
Management of Crohn Disease
2021 Standout
Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs
2021 Standout
Works of A Archambault being referenced
A randomized, double‐blind, placebo‐controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor‐α, in patients with corticosteroid‐dependent Crohn's disease
2005
A randomized, double-blind, placebo-controlled, multi-center trial of the engineered human anti body to TNF (CDP571) for steroid sparing and maintenance of remission in patients with steroid-dependent Crohn's disease
2000
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| A Archambault | 191 | 103 | 77 | 91 | 18 | 327 | |
| J R Crampton | 193 | 91 | 103 | 116 | 25 | 370 | |
| Stefano Kayali | 208 | 87 | 45 | 41 | 19 | 330 | |
| Nuray Uslu | 120 | 106 | 67 | 60 | 22 | 278 | |
| Bilal Ergül | 165 | 67 | 79 | 31 | 32 | 300 | |
| Jernej Brecelj | 101 | 90 | 47 | 70 | 27 | 272 | |
| Zeynal Doğan | 146 | 58 | 66 | 22 | 25 | 256 | |
| J. Sercombe | 124 | 72 | 74 | 32 | 14 | 265 | |
| Aleksandra Sokić-Milutinović | 152 | 43 | 77 | 81 | 34 | 280 | |
| María José Ramírez‐Lázaro | 178 | 43 | 93 | 69 | 18 | 369 | |
| Francisco J. Martínez-Cerezo | 67 | 104 | 141 | 55 | 23 | 323 |
All Works
Loading papers...